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Introduction
Phytotherapy is one of the oldest medical disciplines 
and was traditionally based on empiricism (Reichling et 
al., 2008). Nowadays, its use as an additional integral 
component of evidence based medicine is well accepted 
in human medicine (Finkelmann, 2009). Herbal reme-
dies are generally characterised by a broad therapeutic 
index. They consist of multicomponent mixtures and 
act as multi-target drugs with pleiotropic effects. In Swit-
zerland, veterinary phytotherapy has been relaunched 
in 2006 as a subunit of the Swiss Medical Society for 
Phytotherapy (SMGP-vet). Since 2012, the certificate of 
qualification in veterinary phytotherapy has been ap-
proved by the Swiss Veterinary Association (GST/SVS).
Historically, one of the common approaches to gain 
insight into the medical effects of plants was self-medi-
cation. In non-human animals, self-medication remains 
a controversial subject, because evidence is mostly an-
ecdotal. A few experimentally verified cases of self-med-
ication support the theoretical expectation that animals 
can and do make specific foraging decisions that func-
tion specifically to remediate illness (Huffman and Ca-
ton, 2001; Villalba et al., 2006; Singer et al., 2009). In 
zoological medicine, this concept has first been imple-
mented by primate keeping institutions. Permanent 
access to selected medicinal plants suggested self-medi-
cation and helped maintain the health of certain pri-
mate species (Cousins, 2006).
Zoological medicine is a veterinary discipline that deals 
with a very broad spectrum of taxa and diseases. Often, 
treatment protocols have to be extrapolated from farm 
and companion animals or humans. Clinical daily rou-
tine is limited and treatment decisions are based on 
limited scientific findings and the practitioner’s experi-
ence. Zoo animals are generally highly susceptible to 
capture stress and handling for medical treatment may 
be counterproductive. Hence, the prevention of disease 
has to be emphasised (Hosey et al., 2009). The aim of 
this study was to give a summary on the practical expe-
rience with herbal remedies at Zoo Basel from 2010 to 
2014 as a means to expand the disease prevention and 
therapy spectrum.
Results and Discussion
In the five-year investigation period, Zoo Basel kept an 
average number of 616 animal species, approximately 
two thirds of which belong to invertebrates and fishes. 
Overall, 31 applications in 20 animal species were eval-
uated. A total of 48 medicinal plants was used, either in 
a single (n = 21), or a mixed formulation (n = 10). For 
the classification of indication, the anatomical thera-
peutic chemical classification system for veterinary 
medicine products (ATCvet) was applied (WHO, 2015). 
Most frequently, herbal remedies were used for gastro-
intestinal and metabolic disorders (ATCvet code QA, 
n = 9), followed by dermatological (QD, n = 5), nervous 
(QN, n = 5) and cardiovascular (QB, n = 3) treatments. 
The highest number of treatments was received by the 
order of primates (n = 11), followed by perissodactyla 
(n = 7) and artiodactyla (n = 5).
Thirteen applications were further characterised as es-
tablished standard therapeutics. The criteria for the 
inclusion in this group were on the one hand the proof 
of a repeatable positive effect to treat or prevent diseas-
es, and on the other hand good patient compliance, 
simple administration and a lack of adverse effects. De-
tails of indication, animal species, plant species and 
plant parts used as well as treatment regimens are listed 
in Table 1. We rated the effectiveness of these established 
standard applications subjectively as good (n = 9; treat-
ment led to restitutio ad integrum or prevented disease), 
moderate (n = 1; treatment led to an improvement of a 
medical condition) or variable (n = 3; treatment led to 
an improvement of a medical condition in several but 
not all of the patients). For a comparison between dif-
ferent species including humans, daily dosages were 
converted to dosage per kilogram metabolic body weight 
(MBW = body weight0.75). Live weight from animals was 
either taken from medical or pathological records estab-
lished at Zoo Basel. 
One example of an established application is the proph-
ylaxis of gastrointestinal colic symptoms and diarrhea 
in African elephants (Loxodonta africana) with Triticum 
aestivum L. soaked in water for 30 minutes prior to feed-
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ing (Fig. 1). It is based on own experience and has also 
been described for this indication in livestock and hors-
es as a Swiss ethnoveterinary use report (Klarer et al., 
2013). Since this regular treatment was administered, 
gastrointestinal disorders have been minimized. When-
ever crab-eating macaques suffer from unspecific diar-
rhea, they are offered dried beans of Theobroma cacao L. 
(Fig. 2). This treatment has been used repeatedly with 
success. The mode of action, i. e. the inhibition of salt 
and water secretion by flavonoids, was described in vit-
ro (Schuier et al., 2005). A further established applica-
tion is the use of Citrus x limon, Tilia cordata Mill., 
Pimpinella anisum L., Allium cepa L.and Cuminum cymi-
num L. in the form of an infusion as a cold preparation 
in western lowland gorillas (Gorilla g. gorilla) and other 
great apes. Although the latter two plants are mainly 
known for their effect on the alimentary tract, both 
Tilia cordata Mill. and Pimpinella anisum L. also have an 
impact on respiratory diseases (ESCOP, 2003). The syn-
ergy of antimicrobial, secretolytic and expectorant prop-
erties of this combination may be responsible for the 
good therapeutic outcome.
The remaining 18 applications, listed in Table 2, are 
descriptions of single or few treatments with variable 
effectiveness. The same details of information are pro-
vided as in table 1. We rated the effectiveness of these 
applications as good (n = 12), moderate (n = 2) or un-
satisfactory (n = 4). An example is the use of dried Gink-
go biloba L. as a vasoprotective in a 29-yr-old sun bear 
(Helarctos malayanus) (Fig. 3). This treatment is based on 
a survey of pathological reports that revealed arterio-
sclerosis as a major concern in this species in captivity 
(Hoby et al., 2010). At present, the physical condition 
and the quality of life of the geriatric bear are still rated 
as good (Föllmi et al., 2007). Three applications concern 
the promising treatment of the nervous system in an 
Indian rhinoceros (Rhinoceros unicornis), a western low-
land gorilla and a Sumatran orangutan (Pongo abelii). 
After a change in their social environment, these ani-
ATCvet, Anatomical Therapeutic Chemical Classification System for veterinary medicinal products; QA, alimentary tract and metabolism; QA06, drugs 
for constipation; QA07, antidiarrheals, intestinal anti-inflammatory/antiinfective agents; QB, blood and blood forming organs; QB06, other haemato-
logical agents; QC, cardiovascular system; QC02, antihypertensives; QD, dermatologicals, QD11, other dermatological preparations; QG, genito urinary 
system; QG52, products for teats and udder; QM, musculo-sceletal system; QM01, antiinflammatory and antirheumatic products; QN, nervous system; 
QN06, psychoanaleptics; QR, respiratory system; QR05, cough and cold preparations.
a MBW, metabolic body weight; b b.i.w., twice weekly; c p.o., orally; d s.i.d., once daily; e b.i.d., twice daily; f top., topical; g t.i.d., three times daily.
ATCvet Species Plant (latin name) Plant part Dosage/
MBWa 
(kg0.75)
Application Duration Effecti-
veness
Use in other  
species
QA06 African elephant Triticum aestivum L. furfur 13.7 g b.i.w.b p.o.c continuous good no
QA06 Grant‘s zebra Plantago ovata Forssk semen 693 mg s.i.d.d p.o. few days good domestic equids
QA06 Ostrich Linum usitatissimum L. semen 342 mg s.i.d. p.o. breeding season good great apes
QA07 Chimpanzee Ceratonia siliqua L. fructus 2.1 g b.i.d.e p.o. few days variable various primates
QA07 Crab-eating macaque Theobroma cacao L. semen 522 mg s.i.d. p.o. few days good great apes
QA07 Red forest duiker Picea abies L. summitates 48 mg s.i.d. p.o. few days to weeks variable various mammals
QB06 Chestnut-mandibled 
toucan
Quercus robur L. cortex 23.5 g s.i.d. p.o. continuous moderate various sturnidae, 
Fischer’s turako
QC02 Woolly monkey Allium sativum L.
Viscum album L.
Crateagus laevigata Dc.
bulbus
herba
fructus
27 mg
11 mg
11 mg
s.i.d. p.o. continuous good no
QD11 Indian rhinoceros Calendula officinalis L.  
Echinacea purpurea L.
flos
herba
1.7 mg
1.7 mg
b.i.d. top.f 1 to 2 weeks good no
QG52 Sumatran orangutan Urtica dioica L.
Foeniculum vulgare L. 
Carum carvi L.
Pimpinella anisum L.
Galegae officinalis L.
herba
fructus
fructus
fructus
herba
126 mg
126 mg
126 mg
126 mg
126 mg
b.i.d. p.o. 6 months good various primates
QM01 Ostrich Harpagophytum pro-
cumbens DC. Ex Meisn.
radix 26 mg b.i.d. p.o. 2 to 4 weeks variable various mammals
QN06 Western lowland 
gorilla
Panax ginseng C.A. 
Meyer
radix 1.9 mg s.i.d. p.o. continuous good great apes
QR05 Western lowland 
gorilla
Citrus x limon
Allium cepa L.
Tilia cordata Mill.
Pimpinella anisum L.  
Cuminum cyminum L.
fructus
bulbus
flos
fructus
fructus
112 mg
112 mg
112 mg
t.i.d.g p.o. few days good great apes
Table 1: Established phytotherapeutics and treatment protocols used in different zoo animals at Zoo Basel from 2010 to 2014.
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ATCvet Species Plant (latin name) Plant part Dosage/
MBWa 
(kg0.75)
Application Duration Effecti-
veness
Use in other 
species
QA01 African elephant Calendula officinalis L.
Matricaria recutita L.
Malva sylvestris L.
Commiphora myrrha
Propolis
flos
flos
folium
resina
18 mg
18 mg
18 mg
18 mg
18 mg
s.i.d.b p.o.c 2 weeks good Indian rhinoceros
QA03 Okapi Ceratonia siliqua L.
Gentiana lutea L.
Foeniculum vulgare 
fructus
radix
fructus
222 mg
222 mg
222 mg
s.i.d. p.o. few days good no
QA05 Western lowland 
gorilla
Silybum marianum L. fructus 41 mg b.i.d.d p.o. continuous good no
QC05 Black-handed spider 
monkey
Pinus pinea L. cortex 6.2 mg b.i.d. p.o. few days good no
QC05 Sun bear Ginkgo biloba L. folium 17 mg s.i.d. p.o. continuous good no
QD03 Scarlet pleco Propolis
Aloe barbadensis et 
ferox Mill.
Silybum marianum L.
Matricaria recutita L.
folium
semen
flos
365 mg
37 mg
74 mg
74 mg
s.i.w.e top.f 3 weeks good no
QD11 Red-bellied tamarin Filipendula ulmaria L. herba 42 mg s.i.d. p.o. 2 months unsatis-
factory
various new-world 
primates
QD51 Indian rhinoceros Calendula officinalis L. flos, in bees 
wax 
3.4 mg s.i.d. top. few months unsatis-
factory
no
QD51 Indian rhinoceros Viscum album L. herba, 
lipophilic 
extract 5 
and 2%
0.7 to  
1.7 mg
s.i.d. top. few months unsatis-
factory
no
QG02 Sable antelope Tilia sp. cambium 
corticis
325 mg s.i.d. p.o. few days good no
QL03 Okapi Calendula officinalis L. flos 304 mg s.i.d. p.o. 3 months good no
QL03 Reindeer Eleutherococcus  
senticosus Maxim.
radix 252 mg s.i.d. p.o. 20 days unsatis-
factory
no
QN05 African wild ass Humulus lupulus L.
Lavandula angustifolia 
Mill.
Melissa officinalis L.
Passiflora incarnata L.  
Vitex agnus castus L. 
flos
flos
folium
herba
fructus
4 mg
4 mg
4 mg
4 mg
4 mg
b.i.d. p.o. 10 days unsatis-
factory
Grant’s zebra
QN05 Indian rhinoceros Humulus lupulus L.
Passiflora incarnata L.
Valeriana officinalis L.
flos
herba
radix
4 mg
1.3 mg
1.3 mg
b.i.d. p.o. 3 months good no
QN05 Western lowland 
gorilla
Humulus lupulus L. flos 32 mg b.i.d. p.o. 2 weeks good no
QN06 Sumatran orangutan Hypericum perforatum L. herba 10 mg b.i.d. p.o. 9 months good no
QP53 California sheephead Allium sativum L. bulbus 1.5 g s.i.d. p.o. qg 
48h
6 months moderate no
QR03 Grant‘s zebra Thymus vulgaris L.
Primula veris L.
Eucalyptus globulus
Nigella sativa L.
herba
radix
folium
semen
11 mg
9 mg
15 mg
6 mg
s.i.d. p.o. 10 days, repeated good Okapi
Table 2: Single use of phytotherapeutics and treatment protocols in different zoo animals at Zoo Basel from 2010 to 2014.
ATCvet, Anatomical Therapeutic Chemical Classification System for veterinary medicinal products; QA, alimentary tract and metabolism; QA01, sto-
matological preparations; QA03, drugs for functional gastrointestinal disorders; QA05, bile and liver therapy; QC, cardiovascular system; QC05, vas-
oprotectives; QD, dermatologicals, QD03, preparations for treatment of wounds and ulcers; QD11, other dermatological preparations; QD51, products 
for the treatment of claws and hoofs; QG, genito urinary system; QG02, other gynecologicals; QL, antineoplastic and immunomodulating agents; QL03, 
immunostimulants; QM, musculo-sceletal system; QN, nervous system; QN05, psycholeptics; QN06, psychoanaleptics; QP, antiparasitic products, in-
secticides and repellents; QP53, ectoparasiticides, insecticides and repellents; QR, respiratory system; QR03, drugs for obstructive airway diseases.
a MBW, metabolic body weight; b s.i.d., once daily; c p.o., orally; d b.i.d., twice daily; e s.i.w., once weekly; f top., topical; g q., every.
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mals were treated for a limited period of time with herb-
al remedies that are well known for their calming, 
anxiolytic or mild antidepressive effects from in vivo as 
well as human clinical research (ESCOP, 2003). The 
adult rhinoceros that reared a calf reacted very nervous-
ly about the presence of another female with its calf. 
The sedative and anxiolytic effects of Humulus lupulus 
L., Passiflora incarnata L. and Valeriana officinalis L. tinc-
ture helped to relieve the social stress drastically. The 
use of Humulus lupulus L. alone was successful in the 
integration process of a young female gorilla. When the 
dominant female was treated with the herbal tincture, 
a significant reduction in aggressive behaviour towards 
the new female was recorded. Another application dur-
ing an integration process concerned a subadult orang-
utan. The animal was successfully treated with a regis-
tered human standard preparation based on dried 
Hypericum perforatum L. after a depressive mood was 
suspected (Hoby and Wenker, 2014).
Conclusion
Many of the herbal remedies used in this study were 
based on applications that were established in human 
or domestic veterinary medicine and applied to zoolog-
ical medicine. Others were implemented according to 
practical experience, literature research or exchange with 
colleagues from various zoological institutions, hence 
the results are based on subjective perceptions. The 
presented phytotherapeutics included both the three 
medicinal products (Koi Med Wound Spray, Reinigungs-
trank Natuerlich, Stullmisan®S) that are currently 
commercially available and registered in the Swiss 
veterinary formulary (Tierarzneimittelkompendium, 
2015), and pharmacy specialties, mixtures according to 
authors’ prescriptions, feed additives, feed items and 
human therapeutic agents. Further surveys in other zo-
ological institutions should be carried out to obtain a 
better overview of the knowledge and use of herbal rem-
edies in zoological medicine. 
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Figure 3: A geriatric sun bear ingests dried Ginkgo biloba L. as a vasoprotective agent  
at Zoo Basel.
Figure 1: An adult female African elephant feeding on Triticum aestivum L. as a prophy-
lactic treatment of gastrointestinal colic and diarrhea at Zoo Basel.
Figure 2: A subadult male crab-eating macaque is offered dried beans of Theobroma  
cacao L. to treat against diarrhea at Zoo Basel.
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